Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report) saw unusually-high trading volume on Wednesday. 333,378 shares changed hands during mid-day trading, an increase of 74% from the previous session’s volume of 191,515 shares. The stock last traded at $11.88 and had previously closed at $11.91.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded Sysmex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 18th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.
Read Our Latest Stock Analysis on Sysmex
Sysmex Trading Up 0.2%
Sysmex (OTCMKTS:SSMXY – Get Free Report) last released its quarterly earnings data on Friday, August 7th. The company reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.02. The firm had revenue of $825.85 million for the quarter, compared to analyst estimates of $741.67 million. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. As a group, sell-side analysts anticipate that Sysmex Corporation ADR will post 0.41 EPS for the current fiscal year.
About Sysmex
Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes in vitro diagnostic products and laboratory solutions. The company is best known for its automated hematology analyzers, which are used to examine blood cells, along with related reagents, software and support services.
Its product portfolio also includes systems for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory automation and information-management solutions.
Recommended Stories
- Five stocks we like better than Sysmex
- Disney Is Opening the Door to Netflix—and Changing the Streaming Playbook
- DraftKings Stacks the Deck: The $800M Prediction Pivot
- Wall Street Is Betting These 3 Beaten-Down Stocks Have More Room to Run
- Marvell Technology’s $90 Billion Revenue Goal Puts AI Execution Under a Microscope
Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.
